Citation: Rl. Bick et H. Kaplan, SYNDROMES OF THROMBOSIS AND HYPERCOAGULABILITY - CONGENITAL AND ACQUIRED THROMBOPHILIAS, Clinical and applied thrombosis/hemostasis, 4(1), 1998, pp. 25-50
Citation: Rl. Bick, CURRENT CONCEPTS OF THROMBOSIS - PREVALENT TRENDS FOR DIAGNOSIS AND MANAGEMENT, The Medical clinics of North America, 82(3), 1998, pp. 13-13
Citation: Rl. Bick et H. Kaplan, SYNDROMES OF THROMBOSIS AND HYPERCOAGULABILITY - CONGENITAL AND ACQUIRED CAUSES OF THROMBOSIS, The Medical clinics of North America, 82(3), 1998, pp. 409
Authors:
FAREED J
CALLAS D
HOPPENSTEADT DA
WALENGA JM
BICK RL
Citation: J. Fareed et al., ANTITHROMBIN AGENTS AS ANTICOAGULANTS AND ANTITHROMBOTICS - IMPLICATIONS IN DRUG DEVELOPMENT, The Medical clinics of North America, 82(3), 1998, pp. 569
Citation: Rl. Bick et Sk. Haas, INTERNATIONAL CONSENSUS RECOMMENDATIONS - SUMMARY STATEMENT AND ADDITIONAL SUGGESTED GUIDELINES, The Medical clinics of North America, 82(3), 1998, pp. 613
Citation: Jm. Walenga et Rl. Bick, HEPARIN-INDUCED THROMBOCYTOPENIA, PARADOXICAL THROMBOEMBOLISM, AND OTHER SIDE-EFFECTS OF HEPARIN-THERAPY, The Medical clinics of North America, 82(3), 1998, pp. 635
Citation: Wh. Wehrmacher et al., TICLOPIDINE AND CLOPIDOGREL - DO THEY HAVE DIRECT VASCULAR EFFECTS, Clinical and applied thrombosis/hemostasis, 3(4), 1997, pp. 225-225
Citation: Rl. Bick, THE ANTIPHOSPHOLIPID THROMBOSIS SYNDROMES - A COMMON MULTIDISCIPLINARY MEDICAL PROBLEM, Clinical and applied thrombosis/hemostasis, 3(4), 1997, pp. 270-283
Citation: Rl. Bick, ANTIPHOSPHOLIPID THROMBOSIS SYNDROMES - ETIOLOGY, PATHOPHYSIOLOGY, DIAGNOSIS AND MANAGEMENT, International journal of hematology, 65(3), 1997, pp. 193-213
Citation: Rl. Bick, HEPARIN-THERAPY AND MONITORING - GUIDELINES AND PRACTICE PARAMETERS FOR CLINICAL AND LABORATORY APPROACHES, Clinical and applied thrombosis/hemostasis, 2, 1996, pp. 12-20
Authors:
BICK RL
GIRARDI TV
LACK WJ
COSTA M
TITELBAUM D
Citation: Rl. Bick et al., HODGKINS-DISEASE IN ASSOCIATION WITH HEXAVALENT CHROMIUM EXPOSURE, International journal of hematology, 64(3-4), 1996, pp. 257-262
Citation: Rl. Bick, DISSEMINATED INTRAVASCULAR COAGULATION - OBJECTIVE CLINICAL AND LABORATORY DIAGNOSIS, TREATMENT, AND ASSESSMENT OF THERAPEUTIC RESPONSE, Seminars in thrombosis and hemostasis, 22(1), 1996, pp. 69-88
Authors:
BICK RL
LAUGHLIN HR
COHEN BM
STAUB AJ
MADDEN T
TOOFANIAN A
Citation: Rl. Bick et al., FETAL WASTAGE SYNDROME DUE TO BLOOD PROTEIN PLATELET DEFECTS - RESULTS OF PREVALENCE STUDIES AND TREATMENT OUTCOME WITH LOW-DOSE HEPARIN AND LOW-DOSE ASPIRIN, Clinical and applied thrombosis/hemostasis, 1(4), 1995, pp. 286-292
Citation: Rl. Bick, EVALUATION OF A NEW HYDROXYETHYL STARCH PREPARATION (HEXTEND(TM)) ON SELECTED COAGULATION PARAMETERS, Clinical and applied thrombosis/hemostasis, 1(3), 1995, pp. 215-229
Citation: Wf. Baker et al., THOROTRAST-INDUCED ANGIOSARCOMA COMPLICATED BY DISSEMINATED INTRAVASCULAR COAGULATION AND MICROANGIOPATHIC HEMOLYTIC-ANEMIA - CASE-REPORT AND REVIEW, Clinical and applied thrombosis/hemostasis, 1(3), 1995, pp. 230-240
Authors:
FAREED J
BICK RL
HOPPENSTEADT DA
BERMES EW
Citation: J. Fareed et al., MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION - APPLICATIONS IN THE DIAGNOSIS OF THROMBOSIS AND VASCULAR AND THROMBOTIC DISORDERS, Clinical and applied thrombosis/hemostasis, 1(2), 1995, pp. 87-102
Citation: Rl. Bick, DISSEMINATED INTRAVASCULAR COAGULATION - OBJECTIVE CRITERIA FOR CLINICAL AND LABORATORY DIAGNOSIS AND ASSESSMENT OF THERAPEUTIC RESPONSE, Clinical and applied thrombosis/hemostasis, 1(1), 1995, pp. 3-23